Fibrous dysplasia of the head and neck in Southern Finland: a retrospective study on clinical characteristics, diagnostics, and treatment

被引:2
作者
Vilos, Isabella [1 ,2 ]
Nieminen, Mikko T. [1 ,2 ]
Makitie, Riikka E. [1 ,2 ,3 ]
机构
[1] Helsinki Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, HUS, Kasarmikatu 11-13, Helsinki 00029, Finland
[2] Univ Helsinki, HUS, Kasarmikatu 11-13, Helsinki 00029, Finland
[3] Univ Helsinki, Fac Med, Helsinki, Finland
关键词
Fibrous dysplasia; Head and neck; Bone lesion; Bisphosphonates; Surgery; MCCUNE-ALBRIGHT SYNDROME; INTRAVENOUS PAMIDRONATE; BISPHOSPHONATE THERAPY; BONE; PREDICTORS; DENOSUMAB; SERIES;
D O I
10.1007/s00405-024-08595-z
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Purpose Fibrous dysplasia (FD) is a rare genetic disease with benign bone tumors. FD can affect one (monostotic FD) or multiple bones (polyostotic FD), with craniofacial lesions being common. Because of its rarity, there are only few clinical reports on FD in the head and neck region and its clinical characteristics remain incompletely defined. This study aimed to determine patient demographics, symptoms, diagnostics, and given treatment in patients with FD of the head and neck in a Finnish population.Methods A retrospective review on all patients diagnosed with or treated for FD of the head and neck at the Helsinki University Hospital during 2005-2020.Results In total 74 patients were identified; 54% were male and the mean age 45 years. Overall 95% had monostotic FD. Mandibula and maxilla were the most common anatomic sites. Majority of patients had symptoms, most commonly pain and lesion growth, and 49% had extra-skeletal symptoms. For all, diagnosis was primarily based on imaging findings, biopsies were obtained from 41%. Altogether 54 patients (73%) were managed by observation only, 20 patients (27%) received treatment; ten bisphosphonates, six surgery and four both.Conclusion Although highly variable in its clinical manifestations, head and neck FD lesions are often symptomatic and impose risk for extra-skeletal complications. Treatment is often conservative but should be individually tailored. Future studies are encouraged to better define the disease characteristics and hopefully offer new treatment possibilities.
引用
收藏
页码:3189 / 3195
页数:7
相关论文
共 42 条
[1]   Markers of bone remodeling in neoplastic and bone-related lesions [J].
Arantes Elias, Larissa Santana ;
Costa, Rafael Ferreira ;
Carvalho, Marco Aurelio ;
Batista, Aline Carvalho ;
Silva, Tarcilia Aparecida ;
Leles, Claudio Rodrigues ;
Mendonca, Elismauro Francisco .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2010, 110 (05) :624-631
[2]   Fibrous dysplasia of the orbital region: Series of 12 cases and review of the literature [J].
Bertin, H. ;
Huon, J-F ;
Guillot, P. ;
Longis, J. ;
Corre, P. ;
Bordereau, S. ;
Lebranchu, P. .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2020, 43 (06) :467-476
[3]   Surgical Management of Polyostotic Craniofacial Fibrous Dysplasia: Long-Term Outcomes and Predictors for Postoperative Regrowth [J].
Boyce, Alison M. ;
Burke, Andrea ;
Peck, Carolee Cutler ;
DuFresne, Craig R. ;
Lee, Janice S. ;
Collins, Michael T. .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2016, 137 (06) :1833-1839
[4]   Denosumab treatment for fibrous dysplasia [J].
Boyce, Alison M. ;
Chong, William H. ;
Yao, Jack ;
Gafni, Rachel I. ;
Kelly, Marilyn H. ;
Chamberlain, Christine E. ;
Bassim, Carol ;
Cherman, Natasha ;
Ellsworth, Michelle ;
Kasa-Vubu, Josephine Z. ;
Farley, Frances A. ;
Molinolo, Alfredo A. ;
Bhattacharyya, Nisan ;
Collins, Michael T. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (07) :1462-1470
[5]   Fibrous dysplasia of bone: craniofacial and dental implications [J].
Burke, A. B. ;
Collins, M. T. ;
Boyce, A. M. .
ORAL DISEASES, 2017, 23 (06) :697-708
[6]   Use of high-dose oral bisphosphonate therapy for symptomatic fibrous dysplasia of the skull [J].
Chao, Kevin ;
Katznelson, Laurence .
JOURNAL OF NEUROSURGERY, 2008, 109 (05) :889-892
[7]   Long-term effects of intravenous pamidronate in fibrous dysplasia of bone [J].
Chapurlat, RD ;
Delmas, PD ;
Liens, D ;
Meunier, PJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (10) :1746-1752
[8]   Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment [J].
Chapurlat, RD ;
Hugueny, P ;
Delmas, PD ;
Meunier, PJ .
BONE, 2004, 35 (01) :235-242
[9]   Fibrous dysplasia of bone [J].
Chapurlat, RD ;
Meunier, PJ .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2000, 14 (02) :385-398
[10]   Spontaneous Malignant Transformation in Craniomaxillofacial Fibrous Dysplasia [J].
Cheng, Jie ;
Yu, Hongbo ;
Wang, Dongmiao ;
Ye, Jinhai ;
Jiang, Hongbin ;
Wu, Yunong ;
Shen, Guofang .
JOURNAL OF CRANIOFACIAL SURGERY, 2013, 24 (01) :141-145